Works matching IS 14363291 AND DT 2022 AND VI 25 AND IP 1

Results: 29
    1
    2
    3
    4
    5
    6
    7

    Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 235, doi. 10.1007/s10120-021-01237-x
    By:
    • Takahashi, Yoshikazu;
    • Sunakawa, Yu;
    • Inoue, Eisuke;
    • Kawabata, Ryohei;
    • Ishiguro, Atsushi;
    • Kito, Yosuke;
    • Akamaru, Yusuke;
    • Takahashi, Masazumi;
    • Yabusaki, Hiroshi;
    • Matsuyama, Jin;
    • Makiyama, Akitaka;
    • Tsuda, Masahiro;
    • Suzuki, Takahisa;
    • Yasui, Hisateru;
    • Matoba, Ryo;
    • Kawakami, Hisato;
    • Nakajima, Takako Eguchi;
    • Muro, Kei;
    • Ichikawa, Wataru;
    • Fujii, Masashi
    Publication type:
    Article
    8
    9

    Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE.

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 138, doi. 10.1007/s10120-021-01242-0
    By:
    • Furukawa, Kenichiro;
    • Hatakeyama, Keiichi;
    • Terashima, Masanori;
    • Nagashima, Takeshi;
    • Urakami, Kenichi;
    • Ohshima, Keiichi;
    • Notsu, Akifumi;
    • Sugino, Takashi;
    • Yagi, Taisuke;
    • Fujiya, Keiichi;
    • Kamiya, Satoshi;
    • Hikage, Makoto;
    • Tanizawa, Yutaka;
    • Bando, Etsuro;
    • Kanai, Yae;
    • Akiyama, Yasuto;
    • Yamaguchi, Ken
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor.

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 218, doi. 10.1007/s10120-021-01234-0
    By:
    • Ishida, Tomo;
    • Takahashi, Tsuyoshi;
    • Nishida, Toshirou;
    • Ohnishi, Hiromitsu;
    • Tsuboyama, Takahiro;
    • Sato, Shinsuke;
    • Nakahara, Yujiro;
    • Miyazaki, Yasuhiro;
    • Takeno, Atsushi;
    • Kurokawa, Yukinori;
    • Saito, Takuro;
    • Yamashita, Kotaro;
    • Tanaka, Koji;
    • Yamamoto, Kazuyoshi;
    • Makino, Tomoki;
    • Yamasaki, Makoto;
    • Motoori, Masaaki;
    • Kimura, Yutaka;
    • Nakajima, Kiyokazu;
    • Eguchi, Hidetoshi
    Publication type:
    Article
    16
    17
    18

    Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 207, doi. 10.1007/s10120-021-01230-4
    By:
    • Kang, Yoon-Koo;
    • Morita, Satoshi;
    • Satoh, Taroh;
    • Ryu, Min-Hee;
    • Chao, Yee;
    • Kato, Ken;
    • Chung, Hyun Cheol;
    • Chen, Jen-Shi;
    • Muro, Kei;
    • Kang, Won Ki;
    • Yeh, Kun-Huei;
    • Yoshikawa, Takaki;
    • Oh, Sang Cheul;
    • Bai, Li-Yuan;
    • Tamura, Takao;
    • Lee, Keun-Wook;
    • Hamamoto, Yasuo;
    • Kim, Jong Gwang;
    • Chin, Keisho;
    • Oh, Do-Youn
    Publication type:
    Article
    19
    20

    Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 197, doi. 10.1007/s10120-021-01227-z
    By:
    • Fuchs, Charles S.;
    • Özgüroğlu, Mustafa;
    • Bang, Yung-Jue;
    • Di Bartolomeo, Maria;
    • Mandala, Mario;
    • Ryu, Min-Hee;
    • Fornaro, Lorenzo;
    • Olesinski, Tomasz;
    • Caglevic, Christian;
    • Chung, Hyun C.;
    • Muro, Kei;
    • Van Cutsem, Eric;
    • Elme, Anneli;
    • Thuss-Patience, Peter;
    • Chau, Ian;
    • Ohtsu, Atsushi;
    • Bhagia, Pooja;
    • Wang, Anran;
    • Shih, Chie-Schin;
    • Shitara, Kohei
    Publication type:
    Article
    21
    22

    Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07.

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 188, doi. 10.1007/s10120-021-01224-2
    By:
    • Kakeji, Yoshihiro;
    • Yoshida, Kazuhiro;
    • Kodera, Yasuhiro;
    • Kochi, Mitsugu;
    • Sano, Takeshi;
    • Ichikawa, Wataru;
    • Lee, Sang-Woong;
    • Shibahara, Kazushige;
    • Shikano, Toshio;
    • Kataoka, Masato;
    • Ishiguro, Atsushi;
    • Ojima, Hitoshi;
    • Sakai, Yoshinori;
    • Musha, Nobuyuki;
    • Takase, Tsunenobu;
    • Kimura, Taisei;
    • Takeuchi, Masahiro;
    • Fujii, Masashi
    Publication type:
    Article
    23
    24
    25
    26

    Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 180, doi. 10.1007/s10120-021-01218-0
    By:
    • Iwatsuki, Masaaki;
    • Orita, Hiroyuki;
    • Kobayashi, Kazuma;
    • Hidaka, Shigekazu;
    • Arigami, Takaaki;
    • Kusumoto, Tetsuya;
    • Satake, Hironaga;
    • Oki, Eiji;
    • Tsutsumi, Satoshi;
    • Tobimatsu, Kazutoshi;
    • Shimokawa, Mototsugu;
    • Saeki, Hiroshi;
    • Makiyama, Akitaka;
    • Baba, Hideo;
    • Mori, Masaki
    Publication type:
    Article
    27
    28
    29